Cargando…

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring

BACKGROUND: Hypoglycemia is associated with cardiovascular diseases, increased risk of death. Therefore, it is important to avoid hypoglycemia. The aim of this study was to characterize hypoglycemia according to glycated hemoglobin (HbA1c) level and determine the contributing factors in type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajime, Maiko, Okada, Yosuke, Mori, Hiroko, Uemura, Fumi, Sonoda, Satomi, Tanaka, Kenichi, Kurozumi, Akira, Narisawa, Manabu, Torimoto, Keiichi, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376670/
https://www.ncbi.nlm.nih.gov/pubmed/30815039
http://dx.doi.org/10.1186/s13098-019-0412-3
_version_ 1783395604036059136
author Hajime, Maiko
Okada, Yosuke
Mori, Hiroko
Uemura, Fumi
Sonoda, Satomi
Tanaka, Kenichi
Kurozumi, Akira
Narisawa, Manabu
Torimoto, Keiichi
Tanaka, Yoshiya
author_facet Hajime, Maiko
Okada, Yosuke
Mori, Hiroko
Uemura, Fumi
Sonoda, Satomi
Tanaka, Kenichi
Kurozumi, Akira
Narisawa, Manabu
Torimoto, Keiichi
Tanaka, Yoshiya
author_sort Hajime, Maiko
collection PubMed
description BACKGROUND: Hypoglycemia is associated with cardiovascular diseases, increased risk of death. Therefore, it is important to avoid hypoglycemia. The aim of this study was to characterize hypoglycemia according to glycated hemoglobin (HbA1c) level and determine the contributing factors in type 2 diabetes mellitus (T2DM), using continuous glucose monitoring (CGM). METHODS: T2DM patients (n = 293) receiving inpatient care were divided into five groups according to HbA1c level on admission (Group 1: ≥ 6 to < 7%, Group 2: ≥ 7 to < 8%, Group 3: ≥ 8 to < 9%, Group 4: ≥ 9 to < 10%, and Group 5: ≥ 10%). The frequency of hypoglycemia and factors associated with hypoglycemia were analyzed. RESULTS: Hypoglycemia occurred in 15 patients (5.1%), including 4 (8%), 4 (6%), and 7 (10%) patients of Groups 1, 2, and 3, respectively, but in none of groups 4 and 5. Patients with hypoglycemia of Groups 1 had low insulin secretion and were high among insulin users, those of Groups 2 had low homeostasis model assessment of insulin resistance (HOMA-IR). Those of Group 2 and 3 had significantly lower mean blood glucose levels, those of Group 3 only had significantly lower maximum blood glucose level and percentage of AUC > 180 mg/dL. In any of the HbA1c groups, variations in blood glucose level were significantly larger in patients with hypoglycemia than without. CONCLUSIONS: Hypoglycemia occurred in patients with a wide range of HbA1c on admission (range 6–9%), suggesting that prediction of hypoglycemia based on HbA1c alone is inappropriate. Among patients with low HbA1c, strict control sometimes induce hypoglycemia. Among patients with high HbA1c, the possibility of hypoglycemia should be considered if there is a marked discrepancy between HbA1c and randomly measured blood glucose level. Larger variations in blood glucose level induce hypoglycemia in any of the HbA1c groups. The treatment to reduce variations in blood glucose level is important to prevent hypoglycemia.
format Online
Article
Text
id pubmed-6376670
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63766702019-02-27 Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring Hajime, Maiko Okada, Yosuke Mori, Hiroko Uemura, Fumi Sonoda, Satomi Tanaka, Kenichi Kurozumi, Akira Narisawa, Manabu Torimoto, Keiichi Tanaka, Yoshiya Diabetol Metab Syndr Research BACKGROUND: Hypoglycemia is associated with cardiovascular diseases, increased risk of death. Therefore, it is important to avoid hypoglycemia. The aim of this study was to characterize hypoglycemia according to glycated hemoglobin (HbA1c) level and determine the contributing factors in type 2 diabetes mellitus (T2DM), using continuous glucose monitoring (CGM). METHODS: T2DM patients (n = 293) receiving inpatient care were divided into five groups according to HbA1c level on admission (Group 1: ≥ 6 to < 7%, Group 2: ≥ 7 to < 8%, Group 3: ≥ 8 to < 9%, Group 4: ≥ 9 to < 10%, and Group 5: ≥ 10%). The frequency of hypoglycemia and factors associated with hypoglycemia were analyzed. RESULTS: Hypoglycemia occurred in 15 patients (5.1%), including 4 (8%), 4 (6%), and 7 (10%) patients of Groups 1, 2, and 3, respectively, but in none of groups 4 and 5. Patients with hypoglycemia of Groups 1 had low insulin secretion and were high among insulin users, those of Groups 2 had low homeostasis model assessment of insulin resistance (HOMA-IR). Those of Group 2 and 3 had significantly lower mean blood glucose levels, those of Group 3 only had significantly lower maximum blood glucose level and percentage of AUC > 180 mg/dL. In any of the HbA1c groups, variations in blood glucose level were significantly larger in patients with hypoglycemia than without. CONCLUSIONS: Hypoglycemia occurred in patients with a wide range of HbA1c on admission (range 6–9%), suggesting that prediction of hypoglycemia based on HbA1c alone is inappropriate. Among patients with low HbA1c, strict control sometimes induce hypoglycemia. Among patients with high HbA1c, the possibility of hypoglycemia should be considered if there is a marked discrepancy between HbA1c and randomly measured blood glucose level. Larger variations in blood glucose level induce hypoglycemia in any of the HbA1c groups. The treatment to reduce variations in blood glucose level is important to prevent hypoglycemia. BioMed Central 2019-02-15 /pmc/articles/PMC6376670/ /pubmed/30815039 http://dx.doi.org/10.1186/s13098-019-0412-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hajime, Maiko
Okada, Yosuke
Mori, Hiroko
Uemura, Fumi
Sonoda, Satomi
Tanaka, Kenichi
Kurozumi, Akira
Narisawa, Manabu
Torimoto, Keiichi
Tanaka, Yoshiya
Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
title Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
title_full Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
title_fullStr Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
title_full_unstemmed Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
title_short Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
title_sort hypoglycemia in blood glucose level in type 2 diabetic japanese patients by continuous glucose monitoring
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376670/
https://www.ncbi.nlm.nih.gov/pubmed/30815039
http://dx.doi.org/10.1186/s13098-019-0412-3
work_keys_str_mv AT hajimemaiko hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT okadayosuke hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT morihiroko hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT uemurafumi hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT sonodasatomi hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT tanakakenichi hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT kurozumiakira hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT narisawamanabu hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT torimotokeiichi hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring
AT tanakayoshiya hypoglycemiainbloodglucoselevelintype2diabeticjapanesepatientsbycontinuousglucosemonitoring